Skip to main navigation Skip to search Skip to main content

Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomide

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)433-436
Number of pages4
JournalEuropean Journal of Haematology
Volume106
Issue number3
DOIs
StatePublished - Mar 2021

Keywords

  • beta blockers
  • multiple myeloma
  • pomalidomide
  • progression-free survival

ASJC Scopus subject areas

  • Hematology

Cite this